Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   Activation mechanism of plasmepsins, pepsin-like aspartic proteases from Plasmodium, follows a unique trans-activation pathway
  2. Rathore, Ishan; Mishra, Vandana; Patel, Chandan; Xiao, Huogen; Gustchina,Alla; Wlodawer,Alexander; Yada, Rickey Y; Bhaumik, Prasenjit
  3. The FEBS journal. 2020, MAY 26;
  1. 2.   Structural studies of vacuolar plasmepsins
  2. Bhaumik, P.; Gustchina, A.; Wlodawer, A.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2012, Jan; 1824(1): 207-223.
  1. 3.   Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease
  2. Li, M.; Gustchina, A.; Matuz, K.; Tozser, J.; Namwong, S.; Goldfarb, N. E.; Dunn, B. M.; Wlodawer, A.
  3. Febs Journal. 2011, Nov; 278(22): 4413-4424.
  1. 4.   Structural Insights into the Activation and Inhibition of Histo-Aspartic Protease from Plasmodium falciparum
  2. Bhaumik, P.; Xiao, H. G.; Hidaka, K.; Gustchina, A.; Kiso, Y.; Yada, R. Y.; Wlodawer, A.
  3. Biochemistry. 2011, Oct; 50(41): 8862-8879.
  1. 5.   Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum
  2. Bhaumik, P.; Horimoto, Y.; Xiao, H. G.; Miura, T.; Hidaka, K.; Kiso, Y.; Wlodawer, A.; Yada, R. Y.; Gustchina, A.
  3. Journal of Structural Biology. 2011, Jul; 175(1): 73-84.
  1. 6.   A set of aspartyl protease-deficient strains for improved expression of heterologous proteins in Kluyveromyces lactis
  2. Ganatra, M. B.; Vainauskas, S.; Hong, J. M.; Taylor, T. E.; Denson, J. P. M.; Esposito, D.; Read, J. D.; Schmeisser, H.; Zoon, K. C.; Hartley, J. L.; Taron, C. H.
  3. Fems Yeast Research. 2011, Mar; 11(2): 168-178.
  1. 7.   Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation
  2. Hurt, E. M.; Chan, K.; Serrat, M. A. D.; Thomas, S. B.; Veenstra, T. D.; Farrar, W. L.
  3. Stem Cells. 2010, Mar 31; 28(3): 390-398.
  1. 8.   The Early Years of Retroviral Protease Crystal Structures
  2. Miller, M.
  3. Biopolymers. 2010 94(4): 521-529.
  1. 9.   NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus
  2. Al-Hallaq, R. A.; Conrads, T. P.; Veenstra, T. D.; Wenthold, R. J.
  3. Journal of Neuroscience. 2007, Aug; 27(31): 8334-8343.
  1. 10.   Cockroach allergen Bla g 2: An unusual aspartic proteinase
  2. Wunschmann, S.; Gustchina, A.; Chapman, M. D.; Pomes, A.
  3. Journal of Allergy and Clinical Immunology. 2005, JUL; 116(1): 140-145.
  1. 11.   Crystal structure of cockroach allergen Bla g 2, an unusual zinc binding aspartic protease with a novel mode of self-inhibition
  2. Gustchina, A.; Li, M.; Wunschmann, S.; Chapman, M. D.; Pomes, A.; Wlodawer, A.
  3. Journal of Molecular Biology. 2005, APR 29; 348(2): 433-444.
  1. 12.   HDM2 phosphorylation by MAPKAP kinase 2
  2. Weber, H. O.; Ludwig, R. L.; Morrison, D.; Kotlyarov, A.; Gaestel, M.; Vousden, K. H.
  3. Oncogene. 2005, MAR 17; 24(12): 1965-1972.
  1. 13.   PKC delta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
  2. Jelacic, T.; Linnekin, D.
  3. Blood. 2005, MAR 1; 105(5): 1923-1929.
  1. 14.   Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase
  2. Bibillo, A.; Lener, D.; Klarmann, G. J.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2005 33(1): 171-181.
  1. 15.   Modeling of serine protease prototype reactions with the flexible effective fragment potential quantum mechanical/molecular mechanical method
  2. Nemukhin, A. V.; Grigorenko, B. L.; Rogov, A. V.; Topol, I. A.; Burt, S. K.
  3. Theoretical Chemistry Accounts. 2004 111(1): 36-48.
  1. 16.   Kinetics of the dimerization of retroviral proteases: The "fireman's grip" and dimerization
  2. Ingr, M.; Uhlikova, T.; Strisovsky, K.; Majerova, E.; Konvalinka, J.
  3. Protein Science. 2003 12(10): 2173-2182.
  1. 17.   Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum
  2. Asojo, O. A.; Gulnik, S. V.; Afonina, E.; Yu, B.; Ellman, J. A.; Haque, T. S.; Silva, A. M.
  3. Journal of Molecular Biology. 2003 327(1): 173-181.
  1. 18.   An unusual orientation for Tyr75 in the active site of the aspartic proteinase from Saccharomyces cerevisiae
  2. Gustchina, A.; Li, M.; Phylip, L. H.; Lees, W. E.; Kay, J.; Wlodawer, A.
  3. Biochemical and Biophysical Research Communications. 2002 295(4): 1020-1026.
  1. 19.   Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 angstrom in complex with the inhibitors rs367 and rs370
  2. Asojo, O. A.; Afonina, E.; Gulnik, S. V.; Yu, B.; Erickson, J. W.; Randad, R.; Medjahed, D.; Silva, A. M.
  3. Acta Crystallographica Section D-Biological Crystallography. 2002 58(Part 12): 2001-2008.
  1. 20.   Structural study of the complex between human pepsin and a phosphorus-containing peptidic transition-state analog
  2. Fujinaga, M.; Cherney, M. M.; Tarasova, N. I.; Bartlett, P. A.; Hanson, J. E.; James, M. N. G.
  3. Acta Crystallographica Section D-Biological Crystallography. 2000 56(Part 3): 272-279.
  1. 21.   Structural and biochemical studies of retroviral proteases
  2. Wlodawer, A.; Gustchina, A.
  3. Biochimica et Biophysica Acta - Protein Structure & Molecular Enzymology. 2000 1477(1-2): 16-34.
  1. 22.   Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase
  2. Louis, J. M.; Oroszlan, S.; Tozser, J.
  3. Journal of Biological Chemistry. 1999 274(10): 6660-6666.
  1. 23.   Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor
  2. Prasad, J.; Boyer, F. E.; Domagala, J. M.; Ellsworth, E. L.; Gajda, C.; Hamilton, H. W.; Hagen, S. E.; Markoski, L. J.; Steinbaugh, B. A.; Tait, B. D.; Humblet, C.; Lunney, E. A.; Pavlovsky, A.; Rubin, J. R.; Ferguson, D.; Graham, N.; Holler, T.; Hupe, D.; Nouhan, C.; Tummino, P. J.; Urumov, A.; Zeikus, E.; Zeikus, G.; Gracheck, S. J.; Saunders, J. M.
  3. Bioorganic & Medicinal Chemistry. 1999 7(12): 2775-2800.
  1. 24.   Crystal structure of plant aspartic proteinase prophytepsin: inactivation and vacuolar targeting
  2. Kervinen, J.; Tobin, G. J.; Costa, J.; Waugh, D. S.; Wlodawer, A.; Zdanov, A.
  3. Embo Journal. 1999 18(14): 3947-3955.
  1. 25.   Mass spectrometry as a tool for studying the action of human aspartic proteases on peptides and proteins
  2. Tarasova, N. I.; Czerwinski, G.; Roberts, N. B.; Lubkowski, J.; Sumpter, T. L.; Green, B. N.; Michejda, C. J.; James, M. N. G.
  3. Aspartic Proteinases: Retroviral and Cellular Enzymes. 1998; 436 : 201-206.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel